87 related articles for article (PubMed ID: 2365778)
21. HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection.
Brode E; Kripp U; Breckwoldt W
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):319-29. PubMed ID: 3398648
[TBL] [Abstract][Full Text] [Related]
22. Direct enantiomeric high performance liquid chromatographic separation of propafenone and its major metabolite in serum on a cellulose tris-3,5-dimethylphenyl carbamate chiral stationary phase.
Aboul-Enein HY; Bakr SA
Biomed Chromatogr; 1993; 7(1):38-40. PubMed ID: 8094305
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells.
Kodama I; Suzuki R; Honjo H; Toyama J
Br J Pharmacol; 1992 Nov; 107(3):813-20. PubMed ID: 1335340
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
Heuer H; Gülker H; Hasfeld M; Frenking B; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels.
Kohlhardt M; Fichtner H
Eur J Pharmacol; 1988 Oct; 156(1):55-62. PubMed ID: 2850211
[TBL] [Abstract][Full Text] [Related]
26. Enantioselective HPLC analysis of propafenone and of its main metabolites using polysaccharide and protein-based chiral stationary phases.
Bonato PS; de Abreu LR; de Gaitani CM; Lanchote VL; Bertucci C
Biomed Chromatogr; 2000 Jun; 14(4):227-33. PubMed ID: 10861733
[TBL] [Abstract][Full Text] [Related]
27. [Fatal poisoning with propafenone: a case report documented with blood concentration levels].
Palette C; Maroun N; Gaulier JM; Priolet B; Lachatre G; Bedos JP; Advenier C; Thérond P
Therapie; 2003; 58(4):384-6; discussion 387. PubMed ID: 14679683
[No Abstract] [Full Text] [Related]
28. Diprafenone.
Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
[No Abstract] [Full Text] [Related]
29. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
30. Fatal propafenone overdoses: case reports and a review of the literature.
Clarot F; Goullé JP; Horst M; Vaz E; Lacroix C; Proust B
J Anal Toxicol; 2003; 27(8):595-9. PubMed ID: 14670140
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of R- and S-propafenone and of the main metabolite in plasma.
Böhm R; Ellrich R; Koytchev R
Pharmazie; 1995 Aug; 50(8):542-5. PubMed ID: 7568317
[TBL] [Abstract][Full Text] [Related]
32. [Comment on the contribution by C. Hief, K. Frohner, A. Podczeck, W. Kaltenbrunner, M. Nürnberg and K. Steinbach: Value of a provocation test with diprafenone in patients with bifascicular block].
Wunderlich E
Z Kardiol; 1992 Dec; 81(12):710-4. PubMed ID: 1492441
[No Abstract] [Full Text] [Related]
33. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
[TBL] [Abstract][Full Text] [Related]
34. Determination of the new MDR-modifier PFP 6 and its metabolites in human liver microsomes by high-performance liquid chromatography.
Spatzenegger M; Ecker G; Jäger W
Biomed Chromatogr; 1996; 10(3):127-30. PubMed ID: 8792863
[TBL] [Abstract][Full Text] [Related]
35. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
Boucher M; Chassaing C; Hamel JD; Poirier JM
Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
[TBL] [Abstract][Full Text] [Related]
36. Liquid chromatographic analysis of propafenone enantiomers in human plasma.
Mehvar R
J Chromatogr; 1990 Apr; 527(1):79-89. PubMed ID: 2365794
[TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatographic procedure for the quantitation of propafenone in serum and tissues.
Kannan R; Tidwell D; Singh BN
J Chromatogr; 1983 Feb; 272(2):428-31. PubMed ID: 6833442
[No Abstract] [Full Text] [Related]
38. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
Cai WM; Xu J; Chen B; Zhang FM; Huang YZ; Zhang YD
Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
Brunner F; Kolmayr U; Kukovetz WR
Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous determination of lidocaine, mexiletine, disopyramide, and quinidine in plasma by high performance liquid chromatography.
Dusci LJ; Hackett LP
J Anal Toxicol; 1985; 9(2):67-70. PubMed ID: 3990250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
